Author Christopoulos, Petros

• 2018 | Journal Article
  ​ ​EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non-small cell lung cancer​
  Christopoulos, P.; Endris, V.; Bozorgmehr, F.; Elsayed, M.; Kirchner, M.; Ristau, J. & Buchhalter, I. et al.​ (2018) 
  International Journal of Cancer, 142(12) pp. 2589​-2598​.​ DOI: https://doi.org/10.1002/ijc.31275 
  ​Details  DOI  PMID  PMC 

• 2018 | Journal Article
  ​ ​Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy​
  Bernhardt, D.; Aufderstrasse, S.; König, L.; Adeberg, S.; Bozorgmehr, F.; Christopoulos, P. & Shafie, R. A E. et al.​ (2018) 
  Cancer Management and Research, 10 pp. 6563​-6569​.​ DOI: https://doi.org/10.2147/CMAR.S180990 
  ​Details  DOI  PMID  PMC 

• 2020 | Journal Article
  ​ ​Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer-Cross-Sectional Study of Eligibility and Administration Rates​
  Eichkorn, T.; Bozorgmehr, F.; Regnery, S.; Dinges, L. A.; Kudak, A.; Bougatf, N. & Weber, D. et al.​ (2020) 
  Frontiers in Oncology, 10 art. 586449​.​ DOI: https://doi.org/10.3389/fonc.2020.586449 
  ​Details  DOI  PMID  PMC 

• 2020 | Journal Article | 
  ​ ​Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients​
  von Eiff, D.; Bozorgmehr, F.; Chung, I.; Bernhardt, D.; Rieken, S. ; Liersch, S. & Muley, T. et al.​ (2020) 
  Journal of Thoracic Disease, 12(3) pp. 782​-793​.​ DOI: https://doi.org/10.21037/jtd.2019.12.74 
  ​Details  DOI  PMID  PMC 

• 2020 | Journal Article | 
  ​ ​Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors​
  Rheinheimer, S.; Heussel, C.-P.; Mayer, P.; Gaissmaier, L.; Bozorgmehr, F.; Winter, H. & Herth, F. J. et al.​ (2020) 
  Cancers, 12(4) pp. 1046​.​ DOI: https://doi.org/10.3390/cancers12041046 
  ​Details  DOI  PMID  PMC 

• 2020 | Journal Article | 
  ​ ​Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial​
  Bozorgmehr, F.; Chung, I.; Christopoulos, P.; Krisam, J.; Schneider, M. A.; Brückner, L. & Mueller, D. W. et al.​ (2020) 
  BMC Cancer, 20(1).​ DOI: https://doi.org/10.1186/s12885-020-07264-8 
  ​Details  DOI 

• 2021 | Journal Article
  ​ ​De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer​
  Bozorgmehr, F.; Kazdal, D.; Chung, I.; Kirchner, M.; Magios, N.; Kriegsmann, M. & Allgäuer, M. et al.​ (2021) 
  Frontiers in Oncology, 11 art. 640048​.​ DOI: https://doi.org/10.3389/fonc.2021.640048 
  ​Details  DOI  PMID  PMC 

• 2022 | Journal Article | 
  ​ ​Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis​
  Blasi, M.; Eichhorn, M. E.; Christopoulos, P.; Winter, H.; Heußel, C. P.; Herth, F. J. & El Shafie, R.  et al.​ (2022) 
  BMC Pulmonary Medicine, 22(1) pp. 255​.​ DOI: https://doi.org/10.1186/s12890-022-02043-6 
  ​Details  DOI  PMID  PMC 

• 2022 | Journal Article | Research Paper | 
  ​ ​Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial​
  Bozorgmehr, F.; Christopoulos, P.; Chung, I.; Cvetkovic, J.; Feißt, M.; Krisam, J. & Schneider, M. A. et al.​ (2022) 
  BMC Cancer, 22(1) art. 1011​.​ DOI: https://doi.org/10.1186/s12885-022-10074-9 
  ​Details  DOI 

• 2023 | Journal Article
  ​ ​Upfront and Repeated Stereotactic Radiosurgery in Patients With Brain Metastases From NSCLC​
  Krämer, A. S.; Adeberg, S.; Kronsteiner, D.; König, L.; Schunn, F.; Bozorgmehr, F. & Christopoulos, P. et al.​ (2023) 
  Clinical Lung Cancer,.​ DOI: https://doi.org/10.1016/j.cllc.2023.01.002 
  ​Details  DOI 

• 2023 | Journal Article
  ​ ​Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy​
  Fink, C. A.; Weykamp, F.; Adeberg, S.; Bozorgmehr, F.; Christopoulos, P.; Lang, K. & König, L. et al.​ (2023) 
  Clinical and Translational Radiation Oncology, 42 art. 100665​.​ DOI: https://doi.org/10.1016/j.ctro.2023.100665 
  ​Details  DOI 

• 2023 | Journal Article | Erratum
  ​ ​Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial​
  Bozorgmehr, F.; Chung, I.; Christopoulos, P.; Krisam, J.; Schneider, M. A.; Brückner, L. & Mueller, D. W. et al.​ (2023) 
  BMC Cancer, 23(1).​ DOI: https://doi.org/10.1186/s12885-023-11270-x 
  ​Details  DOI 

• 2023 | Journal Article
  ​ ​Outcome of first-line treatment with pembrolizumab according to KRAS/TP53 mutational status for non-squamous PD-L1 high (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer (nNGM)​
  Bischoff, P.; Reck, M.; Overbeck, T.; Christopoulos, P.; Rittmeyer, A.; Lüders, H. & Kollmeier, J. et al.​ (2023) 
  Journal of Thoracic Oncology,.​ DOI: https://doi.org/10.1016/j.jtho.2023.12.015 
  ​Details  DOI 

• 2023 | Journal Article | 
  ​ ​High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes​
  Eichkorn, T.; Lischalk, J. W.; Stüwe, C.; Tonndorf-Martini, E.; Schubert, K.; Dinges, L.-A. & Regnery, S. et al.​ (2023) 
  Frontiers in Oncology, 12.​ DOI: https://doi.org/10.3389/fonc.2022.1035370 
  ​Details  DOI 

Researcher

Sort

Items per Page